In Nature this week: eight loci linked to PTSD in US Million Veteran Program study, new hybrid metagenomic assembler, and more.
A Japanese researcher may soon be developing rat and mouse embryos with human cells as part of a plan to eventually develop organs for transplants, according to Nature News.
Kentucky law enforcement officials are testing a rapid DNA analyzer in sexual assault cases, CNBC reports.
Three medical writing organizations warn about the harm predatory journals could do to the scientific literature.
In Nucleic Acids Research this week: the hidden human proteome, single-cell-based expression signatures, and more.
Researchers have sequenced and analyzed the genomes of two Komodo dragons, the International Business Times reports.
Reuters reports that slow adoption of CAR-T therapies might be tied to their high prices.
Researchers estimate a high retraction rate among genetics articles, according to The Scientist.
In PNAS this week: intronic STAT3 splice site linked to autosomal dominant primary immunodeficiency condition, human B lymphocyte changes following Epstein-Barr virus exposure, and more.
The US National Institutes of Health outlines how it will be handling restrictions on fetal tissue research, according to ScienceInsider.
The World Health Organization says it accepts its panel's finding that moving forward with clinical applications of germline genome editing would be irresponsible.
Researchers are investigating whether gene drives could help control pests affecting farms, but note that public assent is crucial, Harvest Public Media reports.
In PLOS this week: reference bias effects in ancient genomics, tsetse fly genetic diversity, and more.
The first trial using CRISPR within the human body is to begin this fall to treat a form of blindness.
The Guardian reports that the National Health Service is abandoning its plan to allow healthy people to pay for genomic analysis.
New UK Prime Minister Boris Johnson has selected his brother Jo Johnson, who is largely liked by researchers, to join the cabinet, Nature News reports.
In Science this week: gut microbiome influences the development and function of skeletal muscle in mice, and more.
AdventHealth in Orlando is offering its members free DNA testing, the Associated Press reports, noting that it also plans to use the data collected in research.
Slate discusses efforts to offer DNA phenotyping services, but also its drawbacks.
Canadian firm launches pilot study of residents of Newfoundland and Labrador, The Compass reports.
In Nature this week: new approach allows spatial characterization of microbial species, epigenetic research poised for clinical translation, and more.
Researchers find people can easily be re-identified from anonymized data, MIT's Technology Review reports.
Congressional lawmakers and Trump Administration officials have reached an agreement on a two-year budget deal.
23andMe and GlaxoSmithKline's partnership has uncovered half a dozen drug targets but also raised ethical questions, the Wall Street Journal reports.
In Cell this week: malignant cellular states in glioblastoma, method for predicting long-term outcomes among cancer patients, and more.
A new study finds that a positive lab environment can encourage undergraduates to continue to perform research.
A new analysis suggests non-US citizen STEM PhDs might pass up jobs at US-based startups due to visa concerns.
A UK survey of researchers who identified as LGBT+ and allies uncovered evidence of unwelcoming workplace climates in the physical sciences.
At the Guardian, the University of Edinburgh's Nikolay Ogryzko argues that universities need to better invest in postdocs' careers.